Lower sales of off-patent former blockbuster Lipitor have prompted Pfizer to try and sell off its third Irish API plant in as many years.
New UK proposals to label all drugs as “produced as a result of research on animals” have met with muted response from the ABPI.
Private label gum maker Fertin Pharma has developed an immunity chewing gum that it claims can help guard against the common cold.
In the largest US generic drug safety settlement ever, Ranbaxy USA has agreed to pay $500m after pleading guilty to manufacturing and distributing adulterated drugs, according to the US Justice Department settlement agreement .
Research Pharmaceutical Services' (RPS) former chief information officer (CIO) claims he was unfairly dismissed after discovering the CRO was unlawfully storing potential employees' personal data.
Proposed UK “animal research” labelling laws may backfire if improvements in culture-based toxicology testing continue, according to in vitro CRO Cyprotex.
Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from Theorem and Symbiosis.
BioDuro opened a new laboratory in Shanghai, China on Wednesday to offer a range of customized biopharma services for its Asia Pacific clients.
Just days after raising more than $1B in its IPO, Quintiles announced Wednesday it signed a five-year clinical development agreement with Merck Serono.